NFKB1 and neoplasm: When intestinal epithelial cells are damaged or stimulated by inflammation, the NF-κB pathway is activated, promoting the expression of inflammatory cytokines that can enhance the proliferation, survival, and angiogenesis of tumor cells, thereby playing a role in the progression of CRC [90].